Belmar Pharma Solutions announces hiring of Rob Kilgore as its Chief Financial Officer.
January 1, 2020
To support its growth organically and via acquisition, Belmar has hired Rob Kilgore as its Chief Financial Officer. In that role, Rob will oversee Belmar’s relationships with the capital sources necessary to fund growth, as well as financial planning & analysis, information technology & security, human resources and accounting. Rob has thirty years of experience in finance, corporate law, private equity and technology.
Most recently Rob was the CEO of Absio Corporation, a leading provider of software-driven encryption solutions to public and private enterprise. Prior to assuming leadership of Absio, Rob was the CEO of Wealthtouch, Inc., a provider of aggregated financial reporting software and services to the ultra-high-net worth private bank and family office industry. Rob led Wealthtouch to profitability, supporting its sale to one of the largest financial technology companies in North America. Prior to his career as a technology CEO, Rob was a principal in two private equity firms, and practiced corporate and tax law at one of the largest law firms in the Western United States. Rob received his BA (economics), law degree and MBA (finance) from the University of Michigan.
About Belmar
Belmar began as a local compounding pharmacy in Denver, Colorado in 1985, and has since grown into a single source solution for prescribers, patients, and healthcare facilities all over the country, offering compounded medication, education, and consultation for anti-aging and integrative therapies. Now comprised of Belmar Pharmacy, Belmar Select Outsourcing, Green Mountain Pharmaceuticals, and Belmar Research, Belmar remains dedicated to its cumulative goal of better patient outcomes through quality compounding and effective communication between practitioners, pharmacists, and patients.
